Used in organic synthesis as a key intermediate for the preparation of complex molecules, particularly in the development of pharmaceuticals. It is often employed in Suzuki-Miyaura cross-coupling reactions, which are crucial for forming carbon-carbon bonds in drug discovery and material science. The trifluoromethyl group enhances the compound's stability and bioavailability, making it valuable in designing bioactive compounds. The resulting structures from these couplings, incorporating the piperidine and trifluoromethyl moieties, enable selective binding to biological targets, aiding in the creation of enzyme inhibitors or receptor modulators. This compound is particularly relevant in the synthesis of potential therapeutic agents for diseases such as cancer and neurological disorders.